496921-95-0

Basic information

• Product Name: C₁₆H₂₆O₆C₁₆H₁₈Si
• Synonyms: C₁₆H₂₆O₆C₁₆H₁₈Si
• CAS NO: 496921-95-0
• Molecular Weight: 552.783
• Mol File: 496921-95-0.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: C₁₆H₂₆O₆C₁₆H₁₈Si(CAS DataBase Reference)
• NIST Chemistry Reference: C₁₆H₂₆O₆C₁₆H₁₈Si(496921-95-0)
• EPA Substance Registry System: C₁₆H₂₆O₆C₁₆H₁₈Si(496921-95-0)

Safety Data

• Hazardous Substances Data: 496921-95-0(Hazardous Substances Data)

Upstream product

• 87-89-8 D-myo-inositol 
• 109280-15-1 (1R)-(+)-camphor dimethyl acetal 
• 331679-26-6 2,3-O-(D-1,7,7-trimethylbicyclo[2.2.1]hept-6-ylidene)-D-myo-inositol 
• 58479-61-1 tert-butylchlorodiphenylsilane 

Downstream Products

• 496808-40-3 1D-4,5-O-bisbenzoyl-1-O-(tert-butyldiphenylsilyl)-2,3-O-(D-1',7',7'-trimethyl[2.2.1]bicyclohept-2'-ylidene)-myo-inositol 
• 496808-64-1 1D-O-(1,2-di-O-palmitoyl-sn-glycerol-3-O-methylphospho)-2,3,5,6-O-tetrakis(methoxymethylene)-myo-inositol-4-(dibenzyl phosphate) 
• 1053553-26-6 Octanoic acid (R)-2-{[(1R,2S,3R,4R,5S,6R)-3,4-bis-(bis-benzyloxy-phosphoryloxy)-2,5,6-tris-methoxymethoxy-cyclohexyloxy]-methoxy-phosphoryloxy}-1-octanoyloxymethyl-ethyl ester 
• 496808-68-5 1D-1-O-(tert-butyldiphenylsilyl)-2,3,6-O-tris(methoxymethylene)-myo-inositol 4,5-bis(dibenzylphosphate) 
• 496808-71-0 Phosphoric acid dibenzyl ester (1S,2R,3R,4S,5R,6S)-3-(bis-benzyloxy-phosphoryloxy)-5-(tert-butyl-diphenyl-silanyloxy)-2,4,6-tris-methoxymethoxy-cyclohexyl ester 
• 496808-69-6 1D-2,3,6-O-tris(methoxymethylene)-myo-inositol 4,5-bis(dibenzyl phosphate) 

Relevant articles and documents

PHOSPHATIDYLINOSITOL

The invention relates to a new pharmaceutical compound, diacyl phosphatdylinositol in which both the sn-1 and the sn-2 place are taken by stearic acid (18:0) (diacyl [18:0; 18:0] phosphatidylinositol), more preferably, wherein said diacyl phosphatidylinositol is compound 1 as depicted in Fig. 10 or a racemate of compounds 1 and 2 as depicted in Fig. 10. Said pharmaceutical compound and pharmaceutical compositions comprising this compound are specifically useful for the treatment of a disease or a condition wherein suppression of T-cell activation is desirable, such as asthma, diabetes Type 1, rheumatoid arthritis, inflammatory bowel disease or psoriasis. Also part of the invention are food items containing the compound(s) of the invention and use thereof in a diet to treat or prevent the disease or condition mentioned above